Vaccine maker BioNTech to close several plants in Germany

German vaccine manufacturer BioNTech announced on Monday plans to close three of its plants in Germany. The company stated that the decision will affect approximately 1,800 jobs.

BioNTech became widely known around the world during the Covid-19 pandemic, when it developed and produced, together with partners, one of the first and most widely used vaccines against the coronavirus. During the pandemic, the company rapidly expanded its production capacity to meet global demand for vaccines.

The announcement regarding the plant closures did not go into detail about the specific reasons behind the decision. It is also not known exactly which plants will be closed or what timeline is planned for implementing the changes.

The decision to reduce production capacity may be linked to the changing situation in the vaccine market following the end of the pandemic's acute phase, though the source report provides no additional context.